KLEPTOSE® LINECAPS - New taste-masking solution. 
API’s undesirable taste is one of the most challenging parameters when addressing patient compliance for oral drug delivery systems.
This issue is even more critical in the case of pediatric and geriatric populations. The ability to mask taste impacts the commercial success of the final product by increasing patient compliance and business profitability.
The study evaluates the taste masking performance of two new maltodextrins with high amylose content on NSAIDs.
Other Resources
Our site uses cookies for web statistics usage and to enhance your user experience. For more information visit our cookie policy and learn how to customize cookies setting.
Click Agree to accept cookies and go directly to the site.
Please, turn your device to portrait mode.